Xylem Statistics

Total Valuation

Xylem has a market cap or net worth of EUR 26.80 billion. The enterprise value is 28.24 billion.

Market Cap	26.80B
Enterprise Value	28.24B

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	Feb 18, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+11.62%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	241.45M

Valuation Ratios

The trailing PE ratio is 31.18.

PE Ratio	31.18
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	98.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.83, with an EV/FCF ratio of 31.04.

EV / Earnings	32.85
EV / Sales	3.57
EV / EBITDA	16.83
EV / EBIT	27.39
EV / FCF	31.04

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.22.

Current Ratio	1.75
Quick Ratio	1.19
Debt / Equity	0.22
Debt / EBITDA	1.34
Debt / FCF	2.59
Interest Coverage	25.48

Financial Efficiency

Return on equity (ROE) is 8.45% and return on invested capital (ROIC) is 5.34%.

Return on Equity (ROE)	8.45%
Return on Assets (ROA)	4.30%
Return on Invested Capital (ROIC)	5.34%
Return on Capital Employed (ROCE)	7.92%
Revenue Per Employee	359,567
Profits Per Employee	37,376
Employee Count	23,000
Asset Turnover	0.53
Inventory Turnover	5.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.09% in the last 52 weeks. The beta is 1.08, so Xylem's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-8.09%
50-Day Moving Average	119.02
200-Day Moving Average	120.49
Relative Strength Index (RSI)	36.51
Average Volume (20 Days)	104

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.04

Income Statement

In the last 12 months, Xylem had revenue of EUR 8.27 billion and earned 859.65 million in profits. Earnings per share was 3.53.

Revenue	8.27B
Gross Profit	3.10B
Operating Income	1.08B
Pretax Income	1.05B
Net Income	859.65M
EBITDA	1.63B
EBIT	1.08B
Earnings Per Share (EPS)	3.53

Full Income Statement

Balance Sheet

The company has 1.08 billion in cash and 2.36 billion in debt, giving a net cash position of -1.28 billion.

Cash & Cash Equivalents	1.08B
Total Debt	2.36B
Net Cash	-1.28B
Net Cash Per Share	n/a
Equity (Book Value)	10.51B
Book Value Per Share	42.30
Working Capital	1.70B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.22 billion and capital expenditures -310.05 million, giving a free cash flow of 909.88 million.

Operating Cash Flow	1.22B
Capital Expenditures	-310.05M
Free Cash Flow	909.88M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 37.51%, with operating and profit margins of 13.09% and 10.39%.

Gross Margin	37.51%
Operating Margin	13.09%
Pretax Margin	12.70%
Profit Margin	10.39%
EBITDA Margin	19.66%
EBIT Margin	13.09%
FCF Margin	11.00%

Dividends & Yields

This stock pays an annual dividend of 1.38, which amounts to a dividend yield of 1.25%.

Dividend Per Share	1.38
Dividend Yield	1.25%
Dividend Growth (YoY)	10.56%
Years of Dividend Growth	6
Payout Ratio	39.33%
Buyback Yield	-11.62%
Shareholder Yield	-10.36%
Earnings Yield	3.21%
FCF Yield	3.40%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Xylem has an Altman Z-Score of 4.49.

Altman Z-Score	4.49
Piotroski F-Score	n/a